Eurobio Scientific Société anonyme (EPA: ALERS)

Market Cap	259.13M
Revenue (ttm)	144.73M
Net Income (ttm)	6.64M
Shares Out	10.04M
EPS (ttm)	0.60
PE Ratio	42.96
Forward PE	29.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,613
Open	25.75
Previous Close	25.80
Day's Range	25.70 - 25.80
52-Week Range	13.80 - 25.95
Beta	-0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2024

About ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the ev...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 300
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2023, ALERS's revenue was 130.65 million, a decrease of -14.55% compared to the previous year's 152.90 million. Earnings were 4.84 million, a decrease of -80.61%.